WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Backgroun…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 ...
Business Wire

MSD Announces the Appointment of Tom Burke as Chief Executive Officer

STOUGHTON, Mass.--(BUSINESS WIRE)--MSD, a leading provider of supply chain, medical device management, and technology solutions that speed the transition of care from acute care to low-cost alternate ...
Asia One

IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors

SHENZHEN, China, April 29, 2022 /PRNewswire/ -- Shenzhen IONOVA Life Science Co., Ltd. announces today it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., ...
Business Wire

Themis to be Acquired by MSD

VIENNA--(BUSINESS WIRE)--Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer and MSD (trademark of Merck & Co ...
La Opinión

MSD Animal Health Receives Marketing Approval from European Medicines Agency for BRAVECTO™ (fluralaner) Spot-On Solution for Cats and Dogs

MADISON, N.J.–(BUSINESS WIRE)–$MRK #MSD–MSD Animal Health (known as Merck Animal Health in the United States and ...
Asia One

PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)

DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, ...
TMCnet

MakuSafe Named 2025 MSD Solutions Lab Safety Innovation Challenge Winner

DENVER, Sept. 19, 2025 /PRNewswire/ -- The National Safety Council showcased 10 breakthrough technologies to help prevent ...